{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,2]],"date-time":"2026-11-02T06:27:46Z","timestamp":1793600866754,"version":"4.5.0"},"reference-count":61,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,4,8]],"date-time":"2026-04-08T00:00:00Z","timestamp":1775606400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100002347","name":"Bundesministerium f\u00fcr Forschung, Technologie und Raumfahrt","doi-asserted-by":"publisher","award":["03LW0295"],"award-info":[{"award-number":["03LW0295"]}],"id":[{"id":"10.13039\/501100002347","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002347","name":"Bundesministerium f\u00fcr Forschung, Technologie und Raumfahrt","doi-asserted-by":"publisher","award":["031L0132B"],"award-info":[{"award-number":["031L0132B"]}],"id":[{"id":"10.13039\/501100002347","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["NeuroToxicology"],"published-print":{"date-parts":[[2026,5]]},"DOI":"10.1016\/j.neuro.2026.103446","type":"journal-article","created":{"date-parts":[[2026,4,8]],"date-time":"2026-04-08T16:51:27Z","timestamp":1775667087000},"page":"103446","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["High sensitivity of iPSC-derived motor neurons to the human-relevant botulinum neurotoxin serotypes E and F"],"prefix":"10.1016","volume":"114","author":[{"given":"Maren","family":"Schenke","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alice","family":"Westphal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jasmin","family":"Weisemann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andreas","family":"Rummel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brigitte G.","family":"Dorner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frank","family":"Klawonn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4653-2841","authenticated-orcid":false,"given":"Bettina","family":"Seeger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.neuro.2026.103446_bib1","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1177\/026119291003800401","article-title":"The current scientific and legal status of alternative methods to the LD50 test for botulinum neurotoxin potency testing. The report and recommendations of a ZEBET expert meeting","volume":"38","author":"Adler","year":"2010","journal-title":"Alter. Lab Anim."},{"issue":"7","key":"10.1016\/j.neuro.2026.103446_bib2","doi-asserted-by":"crossref","DOI":"10.3390\/toxins9070230","article-title":"SiMa cells for a serotype specific and sensitive cell-based neutralization test for botulinum toxin A and E","volume":"9","author":"Bak","year":"2017","journal-title":"Toxins"},{"key":"10.1016\/j.neuro.2026.103446_bib3","doi-asserted-by":"crossref","DOI":"10.1155\/2013\/593219","article-title":"Development of a cell-based functional assay for the detection of clostridium botulinum neurotoxin types A and E","volume":"2013","author":"Basavanna","year":"2013","journal-title":"Int J. Microbiol"},{"key":"10.1016\/j.neuro.2026.103446_bib4","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.tiv.2018.07.008","article-title":"vitro potency determination of botulinum neurotoxin serotype A based on its receptor-binding and proteolytic characteristics","volume":"53","author":"Behrensdorf-Nicol","year":"2018","journal-title":"Toxicol. Vitr."},{"issue":"9","key":"10.1016\/j.neuro.2026.103446_bib5","doi-asserted-by":"crossref","DOI":"10.3390\/toxins11090491","article-title":"Immunogenicity associated with botulinum toxin treatment","volume":"11","author":"Bellows","year":"2019","journal-title":"Toxins (Basel)"},{"issue":"4","key":"10.1016\/j.neuro.2026.103446_bib6","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1177\/026119290303100404","article-title":"Growing old disgracefully: the cosmetic use of botulinum toxin","volume":"31","author":"Bottrill","year":"2003","journal-title":"Alter. Lab Anim."},{"issue":"12","key":"10.1016\/j.neuro.2026.103446_bib7","doi-asserted-by":"crossref","DOI":"10.3390\/toxins13120834","article-title":"New modified recombinant botulinum neurotoxin type F with enhanced potency","volume":"13","author":"Burgin","year":"2021","journal-title":"Toxins (Basel)"},{"issue":"4","key":"10.1016\/j.neuro.2026.103446_bib8","first-page":"605","article-title":"A sensitive cell-based assay for testing potency of botulinum neurotoxin type A","volume":"41","author":"Caliskan","year":"2024","journal-title":"ALTEX"},{"issue":"1","key":"10.1016\/j.neuro.2026.103446_bib9","doi-asserted-by":"crossref","DOI":"10.3390\/toxins13010058","article-title":"Botulinum toxin: an update on pharmacology and newer products in development","volume":"13","author":"Choudhury","year":"2021","journal-title":"Toxins (Basel)"},{"issue":"5","key":"10.1016\/j.neuro.2026.103446_bib10","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0063191","article-title":"Metabolic turnover of synaptic proteins: kinetics, interdependencies and implications for synaptic maintenance","volume":"8","author":"Cohen","year":"2013","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.neuro.2026.103446_bib11","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1038\/s42003-023-04495-w","article-title":"Split luciferase-based assay to detect botulinum neurotoxins using hiPSC-derived motor neurons","volume":"6","author":"Cotter","year":"2023","journal-title":"Commun. Biol."},{"issue":"1","key":"10.1016\/j.neuro.2026.103446_bib12","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1186\/s13287-021-02665-3","article-title":"Optogenetically controlled human functional motor endplate for testing botulinum neurotoxins","volume":"12","author":"De Lamotte","year":"2021","journal-title":"Stem Cell Res Ther."},{"issue":"12","key":"10.1016\/j.neuro.2026.103446_bib13","doi-asserted-by":"crossref","first-page":"5226","DOI":"10.1091\/mbc.e08-07-0765","article-title":"Glycosylated SV2A and SV2B mediate the entry of botulinum neurotoxin E into neurons","volume":"19","author":"Dong","year":"2008","journal-title":"Mol. Biol. Cell"},{"key":"10.1016\/j.neuro.2026.103446_bib14","doi-asserted-by":"crossref","DOI":"10.1038\/ncomms7626","article-title":"Generation and expansion of highly pure motor neuron progenitors from human pluripotent stem cells","volume":"6","author":"Du","year":"2015","journal-title":"Nat. Commun."},{"key":"10.1016\/j.neuro.2026.103446_bib15","doi-asserted-by":"crossref","first-page":"3337","DOI":"10.1099\/00221287-143-10-3337","article-title":"Recombinant SNAP-25 is an effective substrate for Clostridium botulinum type A toxin endopeptidase activity in vitro","volume":"143","author":"Ekong","year":"1997","journal-title":"Microbiol. (Read. )"},{"issue":"2-3","key":"10.1016\/j.neuro.2026.103446_bib16","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1007\/BF03033930","article-title":"Clinical use of non-A botulinum toxins: botulinum toxin type C and botulinum toxin type F","volume":"9","author":"Eleopra","year":"2006","journal-title":"Neurotox. Res."},{"issue":"2","key":"10.1016\/j.neuro.2026.103446_bib17","doi-asserted-by":"crossref","DOI":"10.1523\/ENEURO.0349-16.2017","article-title":"The Isl1-Lhx3 complex promotes motor neuron specification by activating transcriptional pathways that enhance its own expression and formation","volume":"4","author":"Erb","year":"2017","journal-title":"eNeuro"},{"issue":"11","key":"10.1016\/j.neuro.2026.103446_bib18","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0049516","article-title":"Botulinum neurotoxin serotype A specific cell-based potency assay to replace the mouse bioassay","volume":"7","author":"Fernandez-Salas","year":"2012","journal-title":"PLoS One"},{"issue":"5","key":"10.1016\/j.neuro.2026.103446_bib19","doi-asserted-by":"crossref","first-page":"208","DOI":"10.3390\/toxins10050208","article-title":"The Expanding Therapeutic Utility of Botulinum Neurotoxins","volume":"10","author":"Fonfria","year":"2018","journal-title":"Toxins"},{"issue":"2","key":"10.1016\/j.neuro.2026.103446_bib20","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1007\/s40257-019-00482-2","article-title":"Updates on botulinum neurotoxins in dermatology","volume":"21","author":"Hanna","year":"2020","journal-title":"Am. J. Clin. Dermatol."},{"issue":"7","key":"10.1016\/j.neuro.2026.103446_bib21","doi-asserted-by":"crossref","DOI":"10.3390\/toxins11070418","article-title":"Rapid detection of botulinum neurotoxins-a review","volume":"11","author":"Hobbs","year":"2019","journal-title":"Toxins (Basel)"},{"issue":"12","key":"10.1016\/j.neuro.2026.103446_bib22","doi-asserted-by":"crossref","first-page":"833","DOI":"10.3390\/toxins13120833","article-title":"Practical application of novel test methods to evaluate the potency of botulinum toxin: a comparison analysis among widely used products in Korea","volume":"13","author":"Hong","year":"2021","journal-title":"Toxins"},{"key":"10.1016\/j.neuro.2026.103446_bib23","doi-asserted-by":"crossref","DOI":"10.1038\/srep15122","article-title":"Coculture of primary motor neurons and schwann cells as a model for in vitro myelination","volume":"5","author":"Hyung","year":"2015","journal-title":"Sci. Rep."},{"key":"10.1016\/j.neuro.2026.103446_bib24","doi-asserted-by":"crossref","first-page":"73","DOI":"10.3389\/fphar.2017.00073","article-title":"Embryonic stem cell-derived neurons grown on multi-electrode arrays as a novel in vitro bioassay for the detection of clostridium botulinum neurotoxins","volume":"8","author":"Jenkinson","year":"2017","journal-title":"Front Pharm."},{"issue":"2","key":"10.1016\/j.neuro.2026.103446_bib25","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1586\/14737159.2014.867808","article-title":"Recent developments in cell-based assays and stem cell technologies for botulinum neurotoxin research and drug discovery","volume":"14","author":"Kiris","year":"2014","journal-title":"Expert Rev. Mol. Diagn."},{"key":"10.1016\/j.neuro.2026.103446_bib26","article-title":"hiPSC-derived neurons provide a robust and physiologically relevant in vitro platform to test botulinum neurotoxins","volume":"11","author":"Lamotte","year":"2020","journal-title":"Front Pharm."},{"issue":"1","key":"10.1016\/j.neuro.2026.103446_bib27","doi-asserted-by":"crossref","first-page":"2338","DOI":"10.1038\/s41467-023-37860-8","article-title":"Structural basis for botulinum neurotoxin E recognition of synaptic vesicle protein 2","volume":"14","author":"Liu","year":"2023","journal-title":"Nat. Commun."},{"issue":"1","key":"10.1016\/j.neuro.2026.103446_bib28","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1042\/BJ20130391","article-title":"Identification of the SV2 protein receptor-binding site of botulinum neurotoxin type E","volume":"453","author":"Mahrhold","year":"2013","journal-title":"Biochem. J."},{"issue":"1","key":"10.1016\/j.neuro.2026.103446_bib29","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1038\/nbt.3049","article-title":"Combinatorial analysis of developmental cues efficiently converts human pluripotent stem cells into multiple neuronal subtypes","volume":"33","author":"Maury","year":"2015","journal-title":"Nat. Biotechnol."},{"issue":"5","key":"10.1016\/j.neuro.2026.103446_bib30","doi-asserted-by":"crossref","DOI":"10.3390\/toxins17050230","article-title":"Preclinical Evaluation of Botulinum Toxin Type E (TrenibotulinumtoxinE) Using the Mouse Digit Abduction Score (DAS) Assay","volume":"17","author":"Nicholson","year":"2025","journal-title":"Toxins (Basel)"},{"issue":"4","key":"10.1016\/j.neuro.2026.103446_bib31","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1002\/mds.21724","article-title":"Botulinum toxin type B vs. type A in toxin-na\u00efve patients with cervical dystonia: Randomized, double-blind, noninferiority trial","volume":"23","author":"Pappert","year":"2008","journal-title":"Mov. Disord."},{"issue":"9","key":"10.1016\/j.neuro.2026.103446_bib32","doi-asserted-by":"crossref","DOI":"10.3390\/toxins10090360","article-title":"Cell-Based Reporter Release Assay to Determine the Potency of Proteolytic Bacterial Neurotoxins","volume":"10","author":"Pathe-Neuschafer-Rube","year":"2018","journal-title":"Toxins"},{"issue":"4","key":"10.1016\/j.neuro.2026.103446_bib33","first-page":"297","article-title":"Botulinum neurotoxin dose-dependently inhibits release of neurosecretory vesicle-vargeted luciferase from neuronal cells","volume":"32","author":"Pathe-Neusch\u00e4fer-Rube","year":"2015","journal-title":"Altex"},{"issue":"25","key":"10.1016\/j.neuro.2026.103446_bib34","doi-asserted-by":"crossref","first-page":"4803","DOI":"10.1016\/j.febslet.2007.08.078","article-title":"A neuronal cell-based botulinum neurotoxin assay for highly sensitive and specific detection of neutralizing serum antibodies","volume":"581","author":"Pellett","year":"2007","journal-title":"FEBS Lett."},{"key":"10.1016\/j.neuro.2026.103446_bib35","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.vascn.2017.04.013","article-title":"Assessment of ELISA as endpoint in neuronal cell-based assay for BoNT detection using hiPSC derived neurons","volume":"88","author":"Pellett","year":"2017","journal-title":"J. Phramacol Toxicol."},{"issue":"12","key":"10.1016\/j.neuro.2026.103446_bib36","doi-asserted-by":"crossref","DOI":"10.3390\/toxins11120713","article-title":"Critical Analysis of Neuronal Cell and the Mouse Bioassay for Detection of Botulinum Neurotoxins","volume":"11","author":"Pellett","year":"2019","journal-title":"Toxins (Basel)"},{"key":"10.1016\/j.neuro.2026.103446_bib37","doi-asserted-by":"crossref","DOI":"10.1002\/1873-3468.13508","article-title":"Botulinum neurotoxins A, B, C, E, and F preferentially enter cultured human motor neurons compared to other cultured human neuronal populations","author":"Pellett","year":"2019","journal-title":"FEBS Lett."},{"key":"10.1016\/j.neuro.2026.103446_bib38","first-page":"3233","article-title":"Botulinum neurotoxin D-C uses synaptotagmin I and II as receptors, and human synaptotagmin II is not an effective receptor for type B, D-C and G toxins","volume":"125","author":"Peng","year":"2012","journal-title":"J. Cell Sci."},{"issue":"7","key":"10.1016\/j.neuro.2026.103446_bib39","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1004177","article-title":"Widespread sequence variations in VAMP1 across vertebrates suggest a potential selective pressure from botulinum neurotoxins","volume":"10","author":"Peng","year":"2014","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.neuro.2026.103446_bib40","doi-asserted-by":"crossref","DOI":"10.1016\/j.jns.2019.116516","article-title":"Safety and pharmacodynamics of a novel recombinant botulinum toxin E (rBoNT-E): Results of a phase 1 study in healthy male subjects compared with abobotulinumtoxinA (Dysport\u00ae)","volume":"407","author":"Pons","year":"2019","journal-title":"J. Neurol. Sci."},{"issue":"4","key":"10.1016\/j.neuro.2026.103446_bib41","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1016\/S0161-813X(01)00042-0","article-title":"Clostridium botulinum neurotoxins act with a wide range of potencies on SH-SY5Y human neuroblastoma cells","volume":"22","author":"Purkiss","year":"2001","journal-title":"Neurotoxicology"},{"issue":"12","key":"10.1016\/j.neuro.2026.103446_bib42","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1003087","article-title":"Botulinum neurotoxins A and E undergo retrograde axonal transport in primary motor neurons","volume":"8","author":"Restani","year":"2012","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.neuro.2026.103446_bib43","series-title":"Uptake and Trafficking of Protein Toxins","first-page":"1","article-title":"Two Feet on the Membrane: Uptake of Clostridial Neurotoxins","author":"Rummel","year":"2017"},{"issue":"6","key":"10.1016\/j.neuro.2026.103446_bib44","doi-asserted-by":"crossref","first-page":"1942","DOI":"10.1111\/j.1471-4159.2009.06298.x","article-title":"Botulinum neurotoxins C, E and F bind gangliosides via a conserved binding site prior to stimulation-dependent uptake with botulinum neurotoxin F utilising the three isoforms of SV2 as second receptor","volume":"110","author":"Rummel","year":"2009","journal-title":"J. Neurochem."},{"issue":"5","key":"10.1016\/j.neuro.2026.103446_bib45","doi-asserted-by":"crossref","DOI":"10.3390\/toxins12050276","article-title":"Analysis of Motor Neurons Differentiated from Human Induced Pluripotent Stem Cells for the Use in Cell-Based Botulinum Neurotoxin Activity Assays","volume":"12","author":"Schenke","year":"2020","journal-title":"Toxins (Basel)"},{"issue":"8","key":"10.1016\/j.neuro.2026.103446_bib46","doi-asserted-by":"crossref","first-page":"585","DOI":"10.3390\/toxins13080585","article-title":"Human-Relevant Sensitivity of iPSC-Derived Human Motor Neurons to BoNT\/A1 and B1","volume":"13","author":"Schenke","year":"2021","journal-title":"Toxins"},{"key":"10.1016\/j.neuro.2026.103446_bib47","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.toxlet.2015.11.015","article-title":"The ability of the YAS and AR CALUX assays to detect the additive effects of anti-androgenic fungicide mixtures","volume":"241","author":"Seeger","year":"2016","journal-title":"Toxicol. Lett."},{"key":"10.1016\/j.neuro.2026.103446_bib48","article-title":"Replacing the mouse bioassay for diagnostics and potency testing of botulinum neurotoxins \u2013 progress and challenges","author":"Stern","year":"2018","journal-title":"Berl. M\u00fcnch Tier. \u00e4rztl Woche"},{"issue":"4","key":"10.1016\/j.neuro.2026.103446_bib49","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1016\/j.febslet.2011.12.037","article-title":"Human synaptotagmin-II is not a high affinity receptor for botulinum neurotoxin B and G: increased therapeutic dosage and immunogenicity","volume":"586","author":"Strotmeier","year":"2012","journal-title":"FEBS Lett."},{"issue":"11","key":"10.1016\/j.neuro.2026.103446_bib50","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1038\/nrn2499","article-title":"Ubiquitin, the proteasome and protein degradation in neuronal function and dysfunction","volume":"9","author":"Tai","year":"2008","journal-title":"Nat. Rev. Neurosci."},{"issue":"2","key":"10.1016\/j.neuro.2026.103446_bib51","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/j.mcn.2003.10.011","article-title":"Schwann cells and astrocytes induce synapse formation by spinal motor neurons in culture","volume":"25","author":"Ullian","year":"2004","journal-title":"Mol. Cell. Neurosci."},{"issue":"1","key":"10.1016\/j.neuro.2026.103446_bib52","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-019-41722-z","article-title":"Functional detection of botulinum neurotoxin serotypes A to F by monoclonal neoepitope-specific antibodies and suspension array technology","volume":"9","author":"von Berg","year":"2019","journal-title":"Sci. Rep."},{"key":"10.1016\/j.neuro.2026.103446_bib53","doi-asserted-by":"crossref","DOI":"10.1016\/j.namjnl.2025.100040","article-title":"Botulinum neurotoxin: Tracking the transition from lethal dose to in vitro models","volume":"1","author":"Watkins","year":"2025","journal-title":"NAM J."},{"issue":"12","key":"10.1016\/j.neuro.2026.103446_bib54","doi-asserted-by":"crossref","first-page":"5035","DOI":"10.3390\/toxins7124861","article-title":"Generation and Characterization of Six Recombinant Botulinum Neurotoxins as Reference Material to Serve in an International Proficiency Test","volume":"7","author":"Weisemann","year":"2015","journal-title":"Toxins (Basel)"},{"issue":"2","key":"10.1016\/j.neuro.2026.103446_bib55","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1093\/toxsci\/kfr354","article-title":"Novel application of human neurons derived from induced pluripotent stem cells for highly sensitive botulinum neurotoxin detection","volume":"126","author":"Whitemarsh","year":"2012","journal-title":"Toxicological sciences official journal Society Toxicology"},{"issue":"10","key":"10.1016\/j.neuro.2026.103446_bib56","doi-asserted-by":"crossref","first-page":"3894","DOI":"10.1128\/IAI.00536-13","article-title":"Characterization of botulinum neurotoxin A subtypes 1 through 5 by investigation of activities in mice, in neuronal cell cultures, and in vitro","volume":"81","author":"Whitemarsh","year":"2013","journal-title":"Infect. Immun."},{"key":"10.1016\/j.neuro.2026.103446_bib57","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.tiv.2016.03.011","article-title":"vitro potency determination of botulinum neurotoxin B based on its receptor-binding and proteolytic characteristics","volume":"34","author":"Wild","year":"2016","journal-title":"Toxicol. Vitr."},{"issue":"4","key":"10.1016\/j.neuro.2026.103446_bib58","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1111\/j.1348-0421.2012.00434.x","article-title":"Specificity of botulinum protease for human VAMP family proteins","volume":"56","author":"Yamamoto","year":"2012","journal-title":"Microbiol. Immunol."},{"issue":"9","key":"10.1016\/j.neuro.2026.103446_bib59","doi-asserted-by":"crossref","first-page":"1870","DOI":"10.1016\/j.stemcr.2023.07.004","article-title":"A novel protocol to derive cervical motor neurons from induced pluripotent stem cells for amyotrophic lateral sclerosis","volume":"18","author":"Yang","year":"2023","journal-title":"Stem Cell Rep."},{"issue":"6","key":"10.1016\/j.neuro.2026.103446_bib60","doi-asserted-by":"crossref","first-page":"847e","DOI":"10.1097\/PRS.0000000000005029","article-title":"Safety and Efficacy of EB-001, a Novel Type E Botulinum Toxin, in Subjects with Glabellar Frown Lines: Results of a Phase 2, Randomized, Placebo-Controlled, Ascending-Dose Study","volume":"142","author":"Yoelin","year":"2018","journal-title":"Plast. Reconstr. Surg."},{"issue":"5858","key":"10.1016\/j.neuro.2026.103446_bib61","doi-asserted-by":"crossref","first-page":"1917","DOI":"10.1126\/science.1151526","article-title":"Induced pluripotent stem cell lines derived from human somatic cells","volume":"318","author":"Yu","year":"2007","journal-title":"Science"}],"container-title":["NeuroToxicology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0161813X26000677?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0161813X26000677?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,11,2]],"date-time":"2026-11-02T05:41:12Z","timestamp":1793598072000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0161813X26000677"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5]]},"references-count":61,"alternative-id":["S0161813X26000677"],"URL":"https:\/\/doi.org\/10.1016\/j.neuro.2026.103446","relation":{},"ISSN":["0161-813X"],"issn-type":[{"value":"0161-813X","type":"print"}],"subject":[],"published":{"date-parts":[[2026,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"High sensitivity of iPSC-derived motor neurons to the human-relevant botulinum neurotoxin serotypes E and F","name":"articletitle","label":"Article Title"},{"value":"NeuroToxicology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neuro.2026.103446","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"103446"}}